APA (7th ed.) Citation

Mellott, T. J., Pender, S. M., Burke, R. M., Langley, E. A., & Blusztajn, J. K. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Mellott, Tiffany J., Sarah M. Pender, Rebecca M. Burke, Erika A. Langley, and Jan Krzysztof Blusztajn. IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Mellott, Tiffany J., et al. IGF2 Ameliorates Amyloidosis, Increases Cholinergic Marker Expression and Raises BMP9 and Neurotrophin Levels in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice. Public Library of Science (PLoS).